• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device stent graft, bypass, superficial femoral artery
Definition For bypassing stenosis in the superficial femoral artery via the femoral vein
Product CodeQWM
Device Class 3

Premarket Approvals (PMA)
2020 2021 2022 2023 2024 2025 2026
0 0 0 2 1 5 1

MDR Year MDR Reports MDR Events
2023 1 1
2024 16 16
2025 8 8
2026 4 4

Device Problems MDRs with this Device Problem Events in those MDRs
Complete Blockage 5 5
Migration 4 4
Device Stenosis 4 4
Obstruction of Flow 3 3
Malposition of Device 3 3
Activation Failure 3 3
Unintended Movement 3 3
Migration or Expulsion of Device 2 2
Failure to Unfold or Unwrap 2 2
Adverse Event Without Identified Device or Use Problem 2 2
Noise, Audible 2 2
Difficult to Remove 2 2
Loosening of Implant Not Related to Bone-Ingrowth 1 1
Device Dislodged or Dislocated 1 1
Difficult to Advance 1 1
Lack of Effect 1 1
Partial Blockage 1 1
Activation, Positioning or Separation Problem 1 1
Detachment of Device or Device Component 1 1
Difficult or Delayed Activation 1 1
Insufficient Device Problem Information 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
Obstruction/Occlusion 10 10
No Clinical Signs, Symptoms or Conditions 7 7
Pain 7 7
Thrombosis/Thrombus 5 5
Ischemia 3 3
Insufficient Information 2 2
Stenosis 2 2
Failure of Implant 2 2
Retroperitoneal Hemorrhage 1 1
Sepsis 1 1
Fistula 1 1
Necrosis 1 1
Exsanguination 1 1
Hematoma 1 1
Respiratory Failure 1 1

-
-